{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:29:05Z","timestamp":1784122145369,"version":"3.55.0"},"reference-count":26,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:p>Objective : To establish whether there is a relationship between hyperprolactinemia and primary thyroid disorders, focusing on patients with autoimmune features. Materials and methods : The medical records of 100 patients with hyperprolactinemia (HPRL) were retrospectively examined. Records of thyroid ultrasonography (USG), basal serum levels of thyroid stimulating hormone, circulating free thyroxine, free triiodothyronine, antithyroglobulin (anti-Tg), and antithyroperoxidase (anti-TPO) antibodies were analyzed. In 100 control subjects, matched by age and gender with HPRL patients, thyroid USG, thyroid function tests (TFTs), and autoantibody panel were obtained. Results : The median PRL in patients was 93 ng\/mL (range: 37-470). Twenty-five patients (25%) and 22 controls (22%) had positive anti-Tg and\/or anti-TPO titers (P = 0.739). The median serum PRL was 98 (37-470) ng\/mL in patients with positive thyroid autoantibodies, and 92 (40-470) ng\/mL in patients who were negative (P = 0.975). Among the individuals with autoantibody positivity TFTs abnormalities were more frequent in HPRL patients (60%, out of 25 patients, 14 with subclinical hypothyroidism and one with hyperthyroidism) than in controls (9.1%, out of 22 patients, 2 with subclinical hyperthyroidism) (P &lt; 0.001). Twenty-seven patients with HPRL and 31 controls had goiter (27 vs. 31%, P = 0.437). Forty-six patients (46%) and 50 (50%) controls had one or more of the features of thyroid disorder, which were goiter, positive thyroid autoantibody, and thyroid function abnormality (P = 0.888). Conclusion : HPRL may be associated with more severe thyroid dysfunction in patients with thyroid autoimmunity.<\/jats:p>","DOI":"10.1590\/0004-2730000002846","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T15:14:51Z","timestamp":1396278891000},"page":"48-52","source":"Crossref","is-referenced-by-count":21,"title":["Thyroid autoimmunity in patients with hyperprolactinemia: an observational study"],"prefix":"10.1590","volume":"58","author":[{"given":"Eda Demir","family":"Onal","sequence":"first","affiliation":[{"name":"Bilkent, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Saglam","sequence":"additional","affiliation":[{"name":"Bilkent, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Sacikara","sequence":"additional","affiliation":[{"name":"Bilkent, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhan","family":"Ersoy","sequence":"additional","affiliation":[{"name":"Bilkent, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekir","family":"Cakir","sequence":"additional","affiliation":[{"name":"Bilkent, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","first-page":"1978","article-title":"Action du lobe ant?erieur de l?hypophyse sur la mont?ee laiteuse","volume":"99","author":"Stricker P","year":"1928","journal-title":"C R Soc Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1152\/ajplegacy.1933.105.1.191","article-title":"The preparation, identification and assay of prolactin ? a hormone of the anterior pituitary","volume":"105","author":"Riddle O","year":"1933","journal-title":"Am J Physiol"},{"issue":"6","key":"ref3","first-page":"639","article-title":"Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects","volume":"17","author":"Ben-Jonathan N","year":"1996","journal-title":"Endocr Rev"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/edrv-15-5-627","article-title":"Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines","volume":"15","author":"Horseman ND","year":"1994","journal-title":"Endocr Rev"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/protein\/8.12.1215","article-title":"Use of a model to understand prolactin and growth hormone specificities","volume":"8","author":"Goffin V","year":"1995","journal-title":"Protein Eng"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0162-3109(83)90023-1","article-title":"Immunomodulation by bromocriptine","volume":"6","author":"Nagy E","year":"1983","journal-title":"Immunopharmacology"},{"issue":"4838","key":"ref7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.3122324","article-title":"Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice","volume":"239","author":"Bernton EW","year":"1989","journal-title":"Science"},{"issue":"41","key":"ref8","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/sj.onc.1203846","article-title":"Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation","volume":"19","author":"Llovera M","year":"2000","journal-title":"Oncogene"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0002-9440(10)65333-3","article-title":"Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions","volume":"154","author":"Leav I","year":"1999","journal-title":"Am J Pathol"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1191\/096120301717164994","article-title":"Prolactin in human systemic lupus erythematosus","volume":"10","author":"Jara LJ","year":"2001","journal-title":"Lupus"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/rheumatology\/32.6.445","article-title":"Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications","volume":"32","author":"Chikanza IC","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1297-319X(03)00151-9","article-title":"Hyperprolactinemia in Sjogren?s syndrome: a patient subset or a disease manifestation?","volume":"71","author":"El Miedany YM","year":"2004","journal-title":"Joint Bone Spine"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3181\/00379727-217-44251","article-title":"Prolactin in autoimmune diseases","volume":"217","author":"Neidhart M","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"issue":"11","key":"ref14","first-page":"1151","article-title":"Effects of prolactin on HLA-DR and CD40 expressions by human thyrocytes","volume":"114","author":"Li J","year":"2001","journal-title":"Chin Med J"},{"issue":"3","key":"ref15","first-page":"147","article-title":"An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs","volume":"90","author":"Giusti M","year":"1999","journal-title":"Recenti Prog Med"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2265.1984.tb03231.x","article-title":"Auto-immune Addison?s disease associated with hyperprolactinaemia","volume":"21","author":"Lever EG","year":"1984","journal-title":"Clin Endocrinol"},{"issue":"8","key":"ref17","first-page":"2302","article-title":"Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings","volume":"80","author":"Thodou E","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/tropej\/50.1.37","article-title":"Serum prolactin in celiac disease","volume":"50","author":"Kapur G","year":"2004","journal-title":"J Trop Pediatr"},{"issue":"2","key":"ref19","article-title":"Prolactin secretion is increased in patients with multiple sclerosis","volume":"25","author":"Azar ST","year":"1999","journal-title":"Endocr Res"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-5728(00)00302-7","article-title":"Prolactin in autoimmunity and antitumor defence","volume":"109","author":"Matera L","year":"2000","journal-title":"J Neuroimmunol"},{"issue":"4","key":"ref21","first-page":"463","article-title":"Generation of autonomously pathogenic neoautoreactive TH1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis","volume":"45","author":"Yu M","year":"1996","journal-title":"J Neurosci"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/acta.0.1040035","article-title":"Thyroid autoimmunity in hyperprolactinaemic disorders","volume":"104","author":"Ferrari C","year":"1983","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.arcmed.2004.11.007","article-title":"Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies","volume":"36","author":"Kramer CK","year":"2005","journal-title":"Arch Med Res"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.euroneuro.2008.04.014","article-title":"Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia","volume":"18","author":"Poyraz BC","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12020-012-9695-y","article-title":"Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results","volume":"42","author":"Rho MH","year":"2012","journal-title":"Endocrine"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s12020-009-9258-z","article-title":"Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto?s thyroiditis: results of a university hospital of 769 patients in Turkey","volume":"36","author":"Erdogan M","year":"2009","journal-title":"Endocrine"}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v58n1\/0004-2730-abem-58-1-0048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T02:46:56Z","timestamp":1565318816000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302014000100048&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0004-27302014000100048"],"URL":"https:\/\/doi.org\/10.1590\/0004-2730000002846","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}